Article Versions Notes

Ocak B, Sahin AB, Ertürk I, Korkmaz M, Erdem D, Cakıroglu U, Karaca M, Dirican A, Olmez OF, Goktas Aydın S, et al. Can Cytoreductive Nephrectomy Improve Outcomes of Nivolumab Treatment in Patients with Metastatic Clear-Cell Renal Carcinoma? Current Oncology. 2024; 31(9):5195-5205. https://doi.org/10.3390/curroncol31090384

Ocak, Birol, Ahmet Bilgehan Sahin, Ismail Ertürk, Mustafa Korkmaz, Dilek Erdem, Umut Cakıroglu, Mustafa Karaca, Ahmet Dirican, Omer Fatih Olmez, Sabin Goktas Aydın, and et al. 2024. "Can Cytoreductive Nephrectomy Improve Outcomes of Nivolumab Treatment in Patients with Metastatic Clear-Cell Renal Carcinoma?" Current Oncology 31, no. 9: 5195-5205. https://doi.org/10.3390/curroncol31090384

Ocak, B., Sahin, A. B., Ertürk, I., Korkmaz, M., Erdem, D., Cakıroglu, U., Karaca, M., Dirican, A., Olmez, O. F., Goktas Aydın, S., Gökyer, A., Kücükarda, A., Gülmez, A., Yumuk, P. F., Demircan, N. C., Oyman, A., Sakalar, T., Karatas, F., Demir, H., ... Evrensel, T. (2024). Can Cytoreductive Nephrectomy Improve Outcomes of Nivolumab Treatment in Patients with Metastatic Clear-Cell Renal Carcinoma? Current Oncology, 31(9), 5195-5205. https://doi.org/10.3390/curroncol31090384